Clinical Trial

Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg in Fast Condition

Name: Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg in Fast Condition — clinical trial record (NCT07372118)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg in fast condition.

Trial Details

NCT Number	NCT07372118
Lead Sponsor	Humanis Saglık Anonim Sirketi
Conditions	Type 2 Diabetes Mellitus (T2DM)
Enrollment	32 participants
Start Date	2025-09-27
Primary Completion	2025-12-29 (estimated)
Study Completion	2026-01-07 (estimated)
Updated on ClinicalTrials.gov	2026-01-28